Drug Profile
Estradiol - Bayer Schering Pharma
Alternative Names: Climarelle™; Estradiol oral - Bayer Schering Pharma; Estradiol transdermal - Bayer Schering Pharma; MenostarLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals; Bayer Schering Pharma
- Developer Bayer HealthCare Pharmaceuticals; Bayer HealthCare Pharmaceuticals Inc.
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Postmenopausal osteoporosis
Most Recent Events
- 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)
- 29 Dec 2006 Schering AG is now called Bayer Schering Pharma AG
- 17 Oct 2005 Data presented at the 16th Annual Meeting of the North American Menopause Society (NAMS-2005) have been added to the Women's health therapeutic trials section